CandlesenseCandlesense
ATRC•benzinga•

AtriCure's Q1 EPS Miss Estimates, Needham Lowers Price Target

Summary

Needham lowered AtriCure Inc's (NASDAQ: ATRC) price target to $67 from $79 due to peer multiple compression, with the Buy rating unchanged.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 4, 2022 by benzinga

← Back to ATRC News
    AtriCure's Q1 EPS Miss Estimates, Needham Lowers Price Target | ATRC Stock News | Candlesense